<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To evaluate the role of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) in <z:hpo ids='HP_0100533'>ocular inflammation</z:hpo>, tear <z:chebi fb="95" ids="16301">nitrite</z:chebi> and nitrates (NN) as NO end products were determined in 11 patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease (BD) and in 11 with non-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet's <z:hpo ids='HP_0000554'>uveitis</z:hpo> (NBU) during the active and remission stages and in 12 healthy controls </plain></SENT>
<SENT sid="1" pm="."><plain>Median (with the range) NN levels were 82.29 (59 </plain></SENT>
<SENT sid="2" pm="."><plain>60-98.25) micromol/l in the active and 98.25 (52.88-246.92) micromol/l in the remission stage of BD; 88.17 (25.99-116.73) micromol/l in the active and 83.00 (31.04-250.28) micromol/l in the remission stage of NBU and 109.17 (88.17-158.74) micromol/l in the controls </plain></SENT>
<SENT sid="3" pm="."><plain>The NN levels in the active stage of BD and NBU were significantly decreased when compared to the controls (p &lt; 0.05; Kruskal-Wallis test) </plain></SENT>
<SENT sid="4" pm="."><plain>Decreased NN levels at the activation stage may be caused by the rapid transformation of the NO to <z:chebi fb="0" ids="25941">peroxynitrites</z:chebi>, which are highly oxidizing and cytotoxic substances </plain></SENT>
</text></document>